These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12433349)

  • 1. [Comparison of three methods to calculate adherence in patients receiving antiretroviral treatment].
    Codina C; Martínez M; Tuset M; del Cacho E; Martín MT; Miró JM; Mallolas J; de Lazzari E; García F; Martínez E; Gatell JM; Ribas J
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):484-90. PubMed ID: 12433349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors predicting lack of adherence to highly active antiretroviral treatment].
    Martín-Sánchez V; Ortega-Valín L; Pérez-Simón Mdel R; Mostaza-Fernández JL; Ortiz de Urbina-González JJ; Rodríguez-María M; Carro-Fernández JA; Cuevas-González MJ; Alcoba-Leza M;
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):491-7. PubMed ID: 12433350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How and why should adherence to antiretroviral therapy].
    Knobel H
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):481-3. PubMed ID: 12433348
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
    Martin M; Del Cacho E; Codina C; Tuset M; De Lazzari E; Mallolas J; Miró JM; Gatell JM; Ribas J
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1263-8. PubMed ID: 18834323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1).
    Burack G; Gaur S; Marone R; Petrova A
    J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.
    Gordillo V; del Amo J; Soriano V; González-Lahoz J
    AIDS; 1999 Sep; 13(13):1763-9. PubMed ID: 10509579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adherence to antiretroviral therapy measured by pill count and drug serum concentrations. Variables associated with a bad adherence].
    Riera M; La Fuente Ld Ld; Castanyer B; Puigventós F; Villalonga C; Ribas MA; Pareja A; Leyes M; Salas A
    Med Clin (Barc); 2002 Sep; 119(8):286-92. PubMed ID: 12236968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors associated with adherence to therapy among HIV-infected patients in Bangui].
    Mouala C; Kaba-Mebri J; Wata JB; Rey JL
    Sante; 2006; 16(2):119-30. PubMed ID: 17116636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up.
    Knobel H; Urbina O; González A; Sorlí ML; Montero M; Carmona A; Guelar A
    HIV Med; 2009 Jul; 10(6):364-9. PubMed ID: 19490179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China.
    Wang X; Wu Z
    AIDS; 2007 Dec; 21 Suppl 8():S149-55. PubMed ID: 18172384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is a missed dose? Implications for construct validity and patient adherence.
    Sankar AP; Nevedal DC; Neufeld S; Luborsky MR
    AIDS Care; 2007 Jul; 19(6):775-80. PubMed ID: 17573598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication refill logistics and refill adherence in HIV.
    Gross R; Zhang Y; Grossberg R
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):789-93. PubMed ID: 15880515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy.
    Shuter J; Bernstein SL
    Nicotine Tob Res; 2008 Apr; 10(4):731-6. PubMed ID: 18418794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.
    Bionghi N; Daftary A; Maharaj B; Msibi Z; Amico KR; Friedland G; Orrell C; Padayatchi N; O'Donnell MR
    BMC Infect Dis; 2018 Apr; 18(1):171. PubMed ID: 29642874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy adherence and highly active antiretroviral therapy: comparison of three sources of information.
    Vincke J; Bolton R
    AIDS Patient Care STDS; 2002 Oct; 16(10):487-95. PubMed ID: 12437860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.